Edition:
India

Cutera Inc (CUTR.OQ)

CUTR.OQ on NASDAQ Stock Exchange Global Select Market

47.40USD
15 Dec 2017
Change (% chg)

$0.20 (+0.42%)
Prev Close
$47.20
Open
$47.00
Day's High
$48.25
Day's Low
$46.95
Volume
319,427
Avg. Vol
79,058
52-wk High
$48.95
52-wk Low
$16.65

Summary

Name Age Since Current Position

J. Daniel Plants

49 2016 Chairman of the Board

James Reinstein

52 2017 President, Chief Executive Officer, Director

Michael Karavitis

2017 Executive Vice President, Chief Technology Officer

Larry Laber

46 2014 Executive Vice President-North America Sales

Miguel Pardos

49 2017 Executive Vice President-International Sales

Darren Alch

49 2017 Vice President, General Counsel, Secretary

Michael Palumbo

2017 Vice President - Global Services

David Apfelberg

75 2016 Independent Director

Gregory Barrett

63 2011 Independent Director

Timothy O'Shea

64 2004 Independent Director

Clinton Severson

69 2015 Independent Director

Elisha Finney

55 2017 Non-Executive Independent Director

John Mills

Integrated Corporate Relations

Biographies

Name Description

J. Daniel Plants

Mr. J. Daniel Plants serves as Chairman of the Board of the Company. J. Daniel Plants was initially appointed to the Company's Board of Directors in January 2015. Mr. Plants is the Founder and Chief Investment Officer of Voce Capital Management LLC (together with its affiliates, "Voce"). Voce and Mr. Plants collectively own 727,031 shares of Cutera as of today, or approximately 5.4% of the Company's outstanding shares. Prior to founding Voce, Mr. Plants held a number of positions at leading Wall Street firms, including executive roles in investment banking at Goldman Sachs and JPMorgan Chase, and as a corporate attorney with Sullivan & Cromwell. Mr. Plants has been a Director of Destination Maternity Corporation since November 2014. He co-founded The Bay Area Urban Debate League and served as its Vice Chairman from 2008 to 2012.

James Reinstein

Mr. James A. Reinstein serves as President, Chief Executive Officer, Director of the Company. Prior to joining Cutera, Mr. Reinstein served as the CEO of Drawbridge Health Inc., a joint venture of GE Ventures and GE Healthcare. Prior to Drawbridge, He was the CEO of Aptus Endosystems from 2012 until its acquisition by Medtronic in 2015. From 2007-2012, he was the EVP and Chief Commercial Officer of Cyberonics, Inc. At Cyberonics, Mr. Reinstein drove the strategy for many of its departments including Research & Development, Clinical Research, and New Business Development and led a global commercial team of over 200 employees, growing revenues by 250% within three years. Prior to Cyberonics, Mr. Reinstein held a variety of management positions of increasing responsibility within Boston Scientific Corporation from 1990-2007, including Vice President and Regional Head of an Asian business unit; Country Director of Boston Scientific de Mexico; and European Head for its Neurovascular Division. He began his career with Proctor & Gamble.

Michael Karavitis

Dr. Michael Karavitis, Ph.D., serves as Executive Vice President, Chief Technology Officer of the Company. Dr. Karavitis returns to Cutera, having previously served as the Company's Vice President of Research and Development from 2012 to 2015. Under his leadership, Cutera released multiple innovative platforms, as well as product line extensions including Enlighten® (the world's first dual wavelength, dual pulse duration picosecond aesthetic laser), Excel HR®, Prowave LX® and two new hand pieces for TruSculpt®, Cutera's body sculpting platform. Prior to returning to Cutera, Dr. Karavitis served as Chief Technology Officer at Femtoblanc, Inc. As an expert in multiple specialties impacting modern laser and light-engine design, Dr. Karavitis engineered the next generation of femtosecond lasers at Femtoblanc. In addition, Dr. Karavitis led various teams of engineers and scientists at a number of successful early to mid-stage companies, including LenSx, Newport Corporation, and Intralase Corporation. Dr. Karavitis graduated with a B.S. in Chemistry from Indiana University, and completed his M.S. and Ph.D. in Chemical and Material Physics at the University of California, Irvine. He is a named inventor on 10 U.S. patents, and has authored 17 articles in peer-reviewed journals.

Larry Laber

Mr. Larry E. Laber serves as our EVP -North America Sales of the comany . Prior to joining Cutera, Mr. Laber spent 12 years at Cynosure, a manufacturer of laser and other light-based aesthetic treatment systems, where he spent his last four years as the Executive Director of Sales for North America. Mr. Laber holds a B.S. in Communications from California State University, Northridge.

Miguel Pardos

Mr. Miguel A. Pardos serves as a EVP-International Sales of the company. Prior to joining Cutera, Mr. Pardos served five years as Vice President of Asia-Pacific for Syneron-Candela, a manufacturer of laser and other light-based aesthetic treatment systems. Before that, he was with GE Healthcare for nine years in a variety of leadership roles in Spain, Germany, Australia, and Singapore. Mr. Pardos holds a B.Sc. in Electrical Engineering from Universidad Politecnica Catalunya, and an Executive M.B.A. from Instituto de Empresa.

Darren Alch

Mr. Darren W. Alch is Vice President, General Counsel, Secretary of the company. Immediately prior to joining Cutera, Mr. Alch served as Vice President, Corporate Legal Affairs with LivaNova PLC (NASDAQ:LIVN), a medical device manufacturer formed following the merger of Cyberonics, Inc. (NASDAQ:CYBX) and Sorin SpA in October 2015. At LivaNova, Mr. Alch had legal responsibility for the company's Cardiac Rhythm Management business unit, as well as responsibility for the Company's global intellectual property function. Prior to the merger, Mr. Alch served as Vice President, General Counsel and Assistant Secretary & Compliance Officer for Cyberonics. Mr. Alch joined Cyberonics in August 2005 as Compliance Officer and Assistant General Counsel with responsibility for the company's worldwide legal affairs. Before joining Cyberonics, he was a shareholder in the health law practice group of the national law firm of Jenkens & Gilchrist, P.C. Prior to Jenkens & Gilchrist, he worked for pharmaceutical giant, Pfizer, Inc. in a sales and marketing capacity. Mr. Alch is a graduate of the U.S. Military Academy at West Point, and served on active duty in the U.S. Army as a field artillery officer.

Michael Palumbo

Mr. Michael Palumbo serves as Vice President - Global Services of the Company. Mr. Palumbo joins Cutera after a 19-year career at Cynosure, during which he held senior level positions in both the international and domestic customer service departments. While at Cynosure, Mr. Palumbo was instrumental in restructuring the company's customer service efforts. At Cutera, Mr. Palumbo will focus on worldwide service initiatives, including enhancing product services and driving customer satisfaction.

David Apfelberg

Dr. David B. Apfelberg, M.D., serves as an Independent Director of the Company. He was Lead Independent Director of Cutera, Inc. He has served as a member of the board of directors since November 1998. Since 1980, Dr. Apfelberg has held various roles at the Stanford University Medical Center, and currently serves as a Clinical Professor of Plastic Surgery. Since 1987, Dr. Apfelberg has also been a consultant for entrepreneurs and venture capital companies in the areas of medical devices and medicine. From June 1991 to May 2001, Dr. Apfelberg was Director of the Plastic Surgery Center in Atherton, California. Dr. Apfelberg is the author of five books on lasers in medicine and is a founding member and past president of the American Society for Lasers in Medicine and Surgery. Dr. Apfelberg holds both a B.M.S., Bachelor of Medical Science, and an M.D. from Northwestern University Medical School.

Gregory Barrett

Mr. Gregory Barrett serves as an Independent Director of Cutera, Inc. Mr. Barrett has been the President and CEO of DFINE, Inc., a private medical device equipment company since September 2013. Mr. Barrett was the Chairman, President and CEO of BÂRRX Medical, Inc., a private medical device company that was acquired by Covidien, a manufacturer and distributer of products to treat gastrointestinal diseases. Prior to joining BÂRRX Medical in February 2004, from January 2001 through August 2003, Mr. Barrett served as President and CEO of ACMI Corporation, a developer of medical visualization and energy systems; Group Vice President at Boston Scientific Corporation; Vice President, Global Sales and Marketing at both Orthofix Corporation (formerly American Medical Electronics) and Baxter Healthcare. Mr. Barrett holds a B.A. in Marketing from the University of Texas, Austin.

Timothy O'Shea

Mr. Timothy J. O'Shea serves as an Independent Director of Cutera, Inc. Mr. O’Shea has been with Oxo Capital since 2008 and serves as a managing director. From 1995 to 2008, he served in a variety of management positions at Boston Scientific, including Corporate Vice President of Business Development from 2000 to 2008. Mr. O’Shea holds a B.A. in history from the University of Detroit.

Clinton Severson

Mr. Clinton H. Severson serves as an Independent Director of Company. Mr. Clint Severson joins Cutera as an independent Director. Mr. Severson has more than 40 years of experience as an executive in the medical and biotechnology industries. He is presently the Chairman, Chief Executive Officer and President of Abaxis, Inc. (Nasdaq:ABAX), a manufacturer of portable blood analysis systems. Mr. Severson also serves on the Boards of Directors of Response Biomedical Corporation (CDNX:RBM) and Trinity Biotech (Nasdaq:TRIB). From February 1989 to May 1996, Mr. Severson served as President and Chief Executive Officer of MAST Immunosystems, Inc., a privately-held medical diagnostics company. In 2007 Mr. Severson received the prestigious 'Entrepreneur of the Year' award from Forbes Magazine.

Elisha Finney

Ms. Elisha Wade Finney is Non-Executive Independent Director of the Company. At Varian, Ms. Finney's management responsibilities included corporate accounting; corporate communications and investor relations; internal audit; risk management; tax and treasury, and corporate information systems. Ms. Finney was named vice president, finance and CFO of Varian Medical Systems in April, 1999, Senior Vice President and CFO in 2005, and Executive Vice President and CFO in 2012. She joined Varian as risk manager in 1988. Prior to joining Varian, Ms. Finney was with the Fox Group in Foster City, California and Beatrice Foods in Chicago, Illinois. She holds a BA degree in risk management and insurance from the University of Georgia as well as an MBA degree from Golden Gate University in San Francisco.

John Mills